You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Human PSMA MAb Radioimmunotherapy for Prostate Cancer
SBC: PROGENICS PHARMACEUTICALS, INC. Topic: N/AProstate cancer is the most common cancer of men in the United States with approximately 189,000 new cases and 30,000 deaths in 2002. Recurrent disease can be controlled temporarily with androgen ablation. However, almost all prostate carcinomas eventuall
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
Development of PSMA-based recombinant protein vaccines
SBC: PROGENICS PHARMACEUTICALS, INC. Topic: N/ADESCRIPTION (provided by applicant): Prostate cancer is the most common cancer of men in the United States with approximately 189,000 new cases and 30,000 deaths in 2002. Recurrent disease can be controlled temporarily with androgen ablation. However, alm
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
Acetylator-based Individualized Dosing of Amonadife
SBC: XANTHUS LIFE SCIENCES, INC. Topic: N/AChemotherapeutic dosing has traditionally been empiric, with all patients receiving the same dose adjusted for body surface area (BSA). Unfortunately, while this may be adequate for the average person, it can be inappropriate for the majority of patien
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
Real-time PolScope microscope for live-cell imaging
SBC: CAMBRIDGE RESEARCH AND INSTRUMENTATION Topic: N/ADESCRIPTION (provided by applicant): Phase I We propose to develop an ultra-sensitive real-time polarized light microscope ("Real-Time PolScope") for analyzing the dynamics of the molecular architecture in living cells, in whole organisms and in cell-f
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
N/A
SBC: Schafer Corporation Topic: N/AN/A
SBIR Phase II 1999 Department of Health and Human Services -
Improving Healthcare Efficiency using Real Time Location
SBC: RADIANSE, INC. Topic: N/ADESCRIPTION (provided by applicant): Radianse Inc. (formerly Sentinel Wireless, LLC) has created an automatic, continuous, real-time indoor positioning system (IPS) specifically for the healthcare environment. The IPS is installed on standard networks
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
Tritum AMS Analysis of Cancer Biomarkers
SBC: NEWTON SCIENTIFIC, INC. Topic: N/ADESCRIPTION (provided by applicant): The goal of this Phase II STTR program is to develop a high-throughput, ultra-sensitive accelerator mass spectrometer for the detection and quantification of tritium in labeled biological molecules. Accelerator mass s
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
Tritum AMS Analysis of Cancer Biomarkers
SBC: NEWTON SCIENTIFIC, INC. Topic: N/ADESCRIPTION (provided by applicant): The goal of this Phase II STTR program is to develop a high-throughput, ultra-sensitive accelerator mass spectrometer for the detection and quantification of tritium in labeled biological molecules. Accelerator mass spectrometry (AMS) is a highly selective means for detecting tritium that can achieve a measurement sensitivity over 1000 times greater than decay ...
STTR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
Hepatic Growth Factor Mimetic for Liver Fibrosis
SBC: Angion Biomedica Corp. Topic: N/ADESCRIPTION (provided by applicant): Hepatic fibrosis, a disease affecting tens of millions of patients worldwide, is the liver scarring response to chronic injury from viral hepatitis B or C, excessive alcohol use, iron overload or extrahepatic obstr
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
Integrated Methods to Discover Novel Disease Pathways
SBC: OSCIENT PHARMACEUTICALS CORPORATION Topic: N/ADESCRIPTION (provided by applicant): Our goal is to accelerate the rate of discovery of novel therapeutic agents by rapidly assigning function to genes with no experimental functional data (NEFD) and organizing them within Protein Interaction Network (PIN
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health